The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy
Authors:
- David CorreaDCDavid Correa
- Stanley L. LiauwSLStanley L. Liauw
Open Access
Abstract
BACKGROUND: Substantial experimental evidence suggests that anticoagulants (ACs) may inhibit cancer growth and metastasis, although the limited data from clinical trials have been inconsistent. The potential antineoplastic effect of ACs was investigated in patients who received radiotherapy for localized prostate cancer.METHODS: The study cohort consisted of 662 patients with adenocarcinoma of the prostate who received radiotherapy (RT) with curative intent. Among those 622 men, 243 (37%) were receiving ACs (warfarin, clopidogrel, and/or aspirin). All patients received external‐beam RT, permanent seed implantation, or a combination of both. Prostate‐specific antigen (PSA) values were monitored for biochemical control of disease.RESULTS: At a median follow‐up of 49 months, the biochemical control rate at 4‐years was significantly better in patients who received ACs at 91% compared with 78% in patients who did not receive ACs (P = .0002). The distant metastasis rate at 4 years also was reduced in the AC group compared with the non‐AC group (1% vs 5%; P = .0248). In subgroup analysis, the improvement in biochemical control was significant only for patients with high‐risk disease. Along with Gleason score, T classification, and initial PSA, the use of AC therapy was associated independently with improved biochemical control in multivariate analysis.CONCLUSIONS: AC therapy was associated with an improvement in biochemical control in patients with prostate cancer who received RT with curative intent. The effect was most prominent in patients who had high‐risk disease. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 30 references indexed in Scilit:
- A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatmentCancer, 2007
- Bleeding Complications With Warfarin UseArchives of internal medicine (1960), 2007
- A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer IncidenceJNCI: Journal of the National Cancer Institute, 2007
- The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced MalignancyJournal of Clinical Oncology, 2005
- Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)Journal of Clinical Oncology, 2004
- Coagulation proteases and human cancerBiochemical Society Transactions, 2002
- Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasisPlatelets, 1999
- Efficacy of Low-Molecular-Weight Heparin and Unf ractionated Heparin to Prevent Adhesion of Human Prostate and Bladder Carcinoma and Melanoma Cells to Bovine Endothelial MonolayersUrologia Internationalis, 1996
- Warfarin inhibition of metastasis: The role of anticoagulationBritish Journal of Surgery, 1987
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983